The Stefanou Foundation is a founder-donor to the Royal Society Enterprise Fund.
The Royal Society is the oldest scientific academy in continuous existence. Its new Enterprise Fund allows the Royal Society to make commercial investments in early-stage innovative businesses emerging from science. The Royal Society realised it could use its brand and networks to create leverage: the investments made by the Royal Society Enterprise Fund could attract others to co-invest and widen the pool of investment in world-class science in the UK.
The Fund is being initially seeded by charitable donations. It will become self-financing, by re-investing its financial gains.
The Fund backs scientific entrepreneurs to get their innovative products to the market place, such as OrganOx, which is developing a medical device that would help to increase significantly the number of human livers available for transplant. In 2015 the company has continued its ongoing European trials, with a total of 40 successful liver transplants using OrganOx technology, and is currently in the process of securing CE approval and commencing FDA trials.
We decided to help set up the Enterprise Fund, in order to help our economy to grow, create and maintain high value science-based jobs in the UK and win competitive advantages in science and technology markets. The vision for the Royal Society Enterprise Fund, to attract others to invest in the commercialisation of world-class science, resonated well with the Foundation's catalytic model of philanthropy